RxLogix Corporation Announces Landmark Partnership with the European Medicines Agency (EMA) for a Cutting-Edge Safety Solution
Amsterdam, Netherlands, December 7th 2023 — RxLogix Corporation, a global leading provider of end-to-end Safety and Pharmacovigilance (PV) Software and Services, is delighted to announce a strategic software agreement with the European Medicines Agency (EMA) to begin the development of the new Signal and Safety Analytics (SSA) platform. The SSA platform, which will include RxLogix […]
